18. Spinocerebellar degeneration Clinical trials / Disease details


Clinical trials : 76 Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR-IIR-17012717
2017-09-202017-09-18Treatment of SCA3/MJD patients with oral DL-3-n-butylphthalide: A randomized, double blind, placebo controlled trialTreatment of SCA3/MJD patients with oral DL-3-n-butylphthalide: A randomized, double blind, placebo controlled trial SCA3/MJDTest group:DL-3-n-butylphthalide;Control group:Placebo;Xiangya Hospital of Central South UniversityNULLRecruiting1060BothTest group:60;Control group:60;2 (Phase 2 study)China